IM Cannabis Corp. (CSE:IMCC)

Market Cap	6.33M
Revenue (ttm)	54.03M
Net Income (ttm)	-10.59M
Shares Out	3.09M
EPS (ttm)	-4.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	140
Open	2.080
Previous Close	1.750
Day's Range	2.050 - 2.080
52-Week Range	1.750 - 10.560
Beta	2.81
RSI	44.10
Earnings Date	Mar 28, 2025

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 95
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IMCC

Financial Performance

In 2024, IM Cannabis's revenue was 54.03 million, an increase of 10.71% compared to the previous year's 48.80 million. Losses were -10.59 million, 11.4% more than in 2023.